公司資料

VBI Vaccines 股價、新聞與催化劑

已下市
股票代碼:
VBIV
交易所:
NASDAQ
產業:
Biopharma
所在地:
United States

股價為何變動

目前無法取得 VBIV 的收盤價變動背景。

公司概覽

業務概覽

VBI Vaccines is an infectious-disease or vaccine company focused on immunity-driven programs where clinical, regulatory, and demand cycles can shift quickly.

所在地與產業分類

Headquartered in the United States and listed on NASDAQ, VBI Vaccines is followed within the infectious-disease universe for its exposure to vaccine and antiviral catalysts.

商業模式特徵

VBI Vaccines combines program development with demand-sensitive launch execution, so investors usually track efficacy, safety, and the commercial path for each major asset.

生技產業定位

Compared with broader biotech peers, VBI Vaccines sits in a catalyst-heavy corner of the landscape where virus, vaccine, and antiviral updates can move sentiment quickly.

未來催化劑

    近期新聞

    新聞標題由機器翻譯,詳情為英文原文。

      相似股票

      商業成熟度、治療領域或催化劑模式相近的同業公司。